Seth Mindell, MD
Internal Medicine · West Bloomfield, MINPI 1720062334
Payments from drug & device makers
Across 273 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$683
- AstraZeneca$537
- Lilly USA, LLC$445
- Amgen$430
- Pfizer$309
- GSK$269
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,497100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $683 |
| AstraZeneca | 32 | $537 |
| Lilly USA, LLC | 30 | $445 |
| Amgen(2 entities) | 21 | $430 |
| Pfizer | 19 | $309 |
| GSK | 18 | $269 |
| Merck | 21 | $263 |
| Boehringer Ingelheim | 11 | $187 |
| Abbott | 8 | $175 |
| AbbVie | 9 | $158 |
| Novartis | 9 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $103 |
| Amarin Pharma, Inc. | 6 | $86 |
| Exact Sciences | 4 | $73 |
| Sanofi Pasteur Inc. | 4 | $71 |
| Bausch Health US, LLC | 1 | $69 |
| Radius Health, Inc. | 4 | $68 |
| Bayer | 2 | $46 |
| Amneal Pharmaceuticals LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Johnson & Johnson | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Tactile Systems Technology Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
| Sanofi | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $11 |
How this compares
$4,497 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 56 | $82,750 |
| EliquisApixaban | 76 | $75,464 |
| MounjaroTirzepatide | 59 | $66,962 |
| OzempicSemaglutide | 46 | $58,363 |
| XareltoRivaroxaban | 33 | $35,564 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $32,006 |
| JanuviaSitagliptin Phosphate | 25 | $24,323 |
| FarxigaDapagliflozin Propanediol | 14 | $15,028 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $13,865 |
| Rosuvastatin Calcium | 711 | $10,578 |
| Effexor XrVenlafaxine Hcl | 12 | $7,265 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $6,074 |
| Metoprolol Succinate | 302 | $6,054 |
| Atorvastatin Calcium | 519 | $5,935 |
| PaxlovidNirmatrelvir/Ritonavir | 32 | $5,652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Effexor Xr, Paxlovid | $309 | $88,381120 claims |
| Boehringer IngelheimJardiance | $187 | $82,75056 claims |
| Lilly USA, LLCMounjaro | $445 | $66,96259 claims |
| Novo NordiskOzempic | $683 | $58,36346 claims |
| MerckJanuvia, Janumet | $263 | $38,18839 claims |
| Johnson & JohnsonXarelto | $32 | $35,56433 claims |
| GSKTrelegy Ellipta | $269 | $32,00635 claims |
| AstraZenecaFarxiga | $537 | $15,02814 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $45 | $3,128268 claims |
| AbbVieSynthroid | $158 | $2,40029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in West Bloomfield
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.